Sign in
Taking peopleNo phase

tVNS and Approach-Avoidance Behavior in Anhedonia and Anxiety

Key facts

Who runs it
Dr. Nils B. Kroemer
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
104 people, planned
Started
23 Mar 2026
Expected to end
31 Dec 2028
Type of study
Interventional, 4 groups
Treatments tested
  • tVNS
  • Sham
Record updated
23 April 2026

Who can take part

Age
18 years to 40 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • BMI between 18,5 and 30,0 kg/m2,
  • between 18 and 40 years of age, and
  • be able and willing to provide informed consent

Who cannot take part

  • take medication (except psychopharmacological medication for MDD or anxiety), patients have to be on stable psychopharmacological medication for at least two months before study participation (minimizing confounding effects)
  • contraindications for MRI (metal implants or claustrophobia)
  • have a lifetime diagnosis of severe neurological disorder (incl. ADHD), schizophrenia, bipolar disorder, or severe substance abuse, posttraumatic stress disorder, obsessive-compulsive disorder, diabetes, epilepsy, or coronary heart disease
  • have fulfilled criteria for an eating disorder or somatic symptom disorder within the last 12-months,
  • have a high risk of suicide,
  • for female individuals if they are pregnant or nursing at the time,
  • impaired movement ability or hearing
  • impaired, uncorrected vision (need contact lenses)
  • contraindications for tVNS hearing aids or diseased skin on the right ear

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study investigates if anhedonia and anxiety symptoms are associated with alterations in reinforcement learning, effort trade-offs for wins vs. punishments, and foraging behavior under threat. Moreover, it will investigate whether these processes can be influenced by a metabolic load and/or transcutaneous vagus nerve stimulation (tVNS). The project consists of (a) an online reinforcement learning study, used to characterize learning, reward sensitivity, and meta-cognition, and (b) a laboratory study in which participants first undergo fMRI while completing an effort-based decision-making task. Second, participants will complete two sessions in VR with randomized active or sham tVNS during a foraging task before and after a caloric load with concurrent physiological recordings.

The 4 groups in the trial

  • Healthy ControlsTreatment being tested

    The healthy control group will include participants without clinically relevant symptoms of anxiety or anhedonia. Inclusion criteria are a STICSA total score \<= 40 and a SHAPS total score below 23.5. Participants in this group must not meet the criteria for a current psychiatric diagnosis defined in the exclusion criteria, as confirmed by the Structured Clinical Interview for DSM (SCID).

    Treatment: tVNS and Sham

  • AnxietyTreatment being tested

    The anxiety group will include participants with elevated anxiety symptoms, defined as a STICSA total score \>= 43. All participants must meet diagnostic criteria for a current anxiety disorder or/and current depressive disorder, confirmed by the SCID.

    Treatment: tVNS and Sham

  • AnhedoniaTreatment being tested

    The anhedonia group will include participants with elevated anhedonia symptoms, defined as a SHAPS total score greater than 29.5. All participants must meet diagnostic criteria for a current depressive disorder or/and current anxiety disorder, confirmed by the SCID.

    Treatment: tVNS and Sham

  • Comorbid anhedonia and anxietyTreatment being tested

    The combined group will include participants with both elevated anxiety and anhedonia symptoms, defined as STICSA \>= 43 and SHAPS \> 29.5, respectively. All participants must meet diagnostic criteria for a current anxiety disorder or/and a current depressive disorder, confirmed by the SCID.

    Treatment: tVNS and Sham

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Vagus Nerve Stimulation and Approach-Avoidance Behavior in Anhedonia and Anxiety
Criteria questions
Built from NCT07476469, who can take part
Record updated
23 April 2026